✦ LIBER ✦

Recent clinical experience with aldose reductase inhibitors

✍ Scribed by H.M.J. Krans

Book ID: 113410009
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 678 KB
Volume: 6
Category: Article
ISSN: 1056-8727
DOI: 10.1016/1056-8727(92)90047-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical experience with sorbinil—An ald

Clinical experience with sorbinil—An aldose reductase inhibitor

✍ Norman E. Pitts; Franzanne Vreeland; Gerald L. Shaw; Michael J. Peterson; Dilip 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Clinical trials with aldose reductase in

Clinical trials with aldose reductase inhibitors

✍ D. Stribling 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 512 KB

Clinical Potential of Aldose Reductase I

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

✍ Dr Yoji Hamada, Jiro Nakamura 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 142 KB

Current progress in clinical trials of a

Current progress in clinical trials of aldose reductase inhibitors in Japan

✍ N. Hotta; H. Kakuta; F. Ando; N. Sakamoto 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Clinical and neurophysiological studies

Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy

✍ I. G. Lewin; I. A. D. O'Brien; M. H. Morgan; R. J. M. Corrall 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 436 KB

The effect of sorbinil (200 mg daily for 4 weeks) was examined in 13 patients, mean age 59.7 years (range 42-72 years), with symptomatic diabetic neuropathy of mean duration 6 year (range 1-18 years). In this double-blind, placebo-controlled crossover trial, studies were made of motor, sensory and a

Recent advances in aldose reductase inhi

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

✍ Miyamoto, Shuichi 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 164 KB